Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Cerebrospinal fluid (CSF) biomarkers play an important role in diagnosing Alzheimer’s disease (AD) which is characterized by amyloid-β (Aβ) amyloidosis. Here, we used two App knock-in mouse models, App(NL-F/NL-F) and App(NL-G-F/NL-G-F), exhibiting AD-like Aβ pathology to analyze how the brain pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Richeng, Smailovic, Una, Haytural, Hazal, Tijms, Betty M., Li, Hao, Haret, Robert Mihai, Shevchenko, Ganna, Chen, Gefei, Abelein, Axel, Gobom, Johan, Frykman, Susanne, Sekiguchi, Misaki, Fujioka, Ryo, Watamura, Naoto, Sasaguri, Hiroki, Nyström, Sofie, Hammarström, Per, Saido, Takaomi C., Jelic, Vesna, Syvänen, Stina, Zetterberg, Henrik, Winblad, Bengt, Bergquist, Jonas, Visser, Pieter Jelle, Nilsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254429/
https://www.ncbi.nlm.nih.gov/pubmed/35787306
http://dx.doi.org/10.1186/s40478-022-01398-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254429/
https://www.ncbi.nlm.nih.gov/pubmed/35787306
http://dx.doi.org/10.1186/s40478-022-01398-5

Ejemplares similares